Pancreas, Pancreatectomy
Test Code: 1430 | CPT Code: 88309 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
PAP Smear (Thin Prep Smears), Gynecological Cytology
Test Code: 1440 | CPT Code: 88164 |
Specimen Type: Smears | |
Sample Volume: Smear fixed immediately with spray fixative or 95% ethyl alcohol | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Slide broken in transit beyond ability to repair | |
Methodology: Conventional smears | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The conventional PAP Smear is intended for use in screening for the presence of atypical cells, cervical cancer, or its precursor lesions, as well as all other cytologic categories. |
|
Run Day: Daily, except Fri | |
Reporting Day: Next day |
PAP Smear, Conventional
Test Code: 6285 | CPT Code: 88164 |
Specimen Type: Smears | |
Sample Volume: Smear fixed immediately with spray fixative or 95% ethyl alcohol | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Slide broken in transit beyond ability to repair | |
Methodology: Conventional smears | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The conventional PAP smear is intended for use in screening for the presence of atypical cells, cervical cancer, or its precursor lesions, as well as all other cytologic categories. |
|
Run Day: Daily, except Fri | |
Reporting Day: 2nd day |
Papilloma virus, Human, Amplified Probe Technique Infectious Agent Detection by Nucleic acid (DNA or RNA)
Test Code: 4735 | CPT Code: 87621 |
Specimen Type: Thin prep vial | |
Sample Volume: 10 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: NA | |
Methodology: HPV Microarray | |
Special Requirements: No special precautions needed | |
Clinical Significance: Helps in detection of high risk and low risk HPV genotypes present in the sample. Clinically important for the screening of cervical cancer. |
|
Run Day: Sun, Wed | |
Reporting Day: Next day |
Parathyroid Hormone (PTH), Blood
Test Code: 484 | CPT Code: 83970 |
Specimen Type: Plasma EDTA (Whole blood in a lavender-top (EDTA) tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Grosshemolysis and lipemia | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: The major function of PTH is to maintain the serum total calcium concentration within a narrow range. The net effects of PTH are to increase the serum concentration of calcium and to decrease that of phosphate. The assay is useful in making the diagnosis of primary hyperparathyroidism, secondary hyperparathyroidism, and in differential diagnosis of hypercalcemia. The assay helps to distinguish hypercalcemia |
|
Run Day: Sat, Mon, Wed | |
Reporting Day: Next day |
Parathyroids, Parathyroidectomy
Test Code: 1403 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Parvovirus B19 Antibodies, IgG, Serum
Test Code: 13954 | CPT Code: 86747 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Grosshemolysis, icteric and hyperlipemic | |
Methodology: Enzyme immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Parvovirus B19 preferentially replicates in erythroid progenitor cells. Infection with parvovirus B19 occurs early in life and the virus is transmitted by respiratory secretion and occasionally by blood products. Parvovirus B19 may result in an asymptomatic infection or produce a wide spectrum of human diseases, including persistent anemia especially in immunocompromised/ transplant patients, and infants. This assay is used in serologic detection of recent or past parvovirus B19 infection. |
|
Run Day: Tue | |
Reporting Day: Same day |
Parvovirus B19 Antibody, IgM, Serum
Test Code: 13294 | CPT Code: 86747 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Grosshemolysis, icteric and hyperlipemic | |
Methodology: Enzyme immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Parvovirus B19 preferentially replicates in erythroid progenitor cells. Infection with parvovirus B19 occurs early in life and the virus is transmitted by respiratory secretion and occasionally by blood products. Parvovirus B19 may result in an asymptomatic infection or produce a wide spectrum of human diseases, including persistent anemia especially in immunocompromised/ transplant patients, and infants. This assay is used in serologic detection of recent or past parvovirus B19 infection. |
|
Run Day: Tue | |
Reporting Day: Same day |
Parvovirus B19, Molecular Detection, PCR
Test Code: 13756 | CPT Code: 87798 |
Specimen Type: Plasma EDTA/ whole blood EDTA/ bone marrow EDTA (lavender-top tubes) | |
Sample Volume: 0.5 mL for each tube | |
Transport Condition: Refrigerated whole blood & bone marrow, frozen plasma | |
Specimen Rejection Criteria: Nil | |
Methodology: PCR | |
Special Requirements: Specimen source is required. | |
Clinical Significance: Parvovirus B19 preferentially replicates in erythroid progenitor cells. Infection with parvovirus B19 occurs early in life and the virus is transmitted by respiratory secretion and occasionally by blood products. Parvovirus B19 may result in an asymptomatic infection or produce a wide spectrum of human diseases, including persistent anemia especially in immunocompromised/ transplant patients, and infants. This assay is used for rapid detection of parvovirus B19 DNA in blood/ bone marrow by PCR, as an aid in the diagnosis of infection by this pathogen. |
|
Run Day: Tue | |
Reporting Day: 4th day |
Pelvic exenteration
Test Code: 1431 | CPT Code: Use individual CPTCodes |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Penis, Penectomy
Test Code: 1404 | CPT Code: 88309 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Peripheral Nerve Biopsy
Test Code: 1383 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Phenobarbital, Serum
Test Code: 7093 | CPT Code: 80184 |
Specimen Type: Serum collected in a red-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Serum collected in a yellow-top tube separator tube | |
Methodology: Immunoassay | |
Special Requirements: Results from specimen collected 2 to 4 hrs after dose can be misleading. Treatment history required | |
Clinical Significance: Phenobarbital is a general central nervous system suppressant used in the control of generalized and partial seizures. Phenobarbital assay is useful in monitoring for appropriate therapeutic concentration of the drug and in assessing compliance or toxicity. |
|
Run Day: Tue, Thurs | |
Reporting Day: Next day |
Phenylalanine, Neonatal Screening
Test Code: 3620 | CPT Code: 84030 |
Specimen Type: Dry Blood Spots | |
Sample Volume: 2 Dry Blood Spots | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: NA | |
Methodology: Enzyme immunoassay | |
Special Requirements: Newborn infants are screened regardless of gestational age, weight, feeding or healthstatus between 48 and 72 hours of life. | |
Clinical Significance: Phenylketonuria is an inherited autosomal recessive condition caused by an enzyme deficiency (phenylalanine hydroxylase) which results in the inability |
|
Run Day: Mon, Thurs | |
Reporting Day: Next day |
Phenytoin, Serum
Test Code: 1129 | CPT Code: 80185 |
Specimen Type: Serum collected in a red-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Serum collected in a yellow-top tube separator tube | |
Methodology: ECLIA | |
Special Requirements: No special precautions needed | |
Clinical Significance: Phenytoin is an anticonvulsant used for the treatment of generalized tonic-clonic |
|
Run Day: Mon, Wed, Sat | |
Reporting Day: Next day |
Philadelphia Chromosome (BCR/ ABL Gene Rearrangement), Quantitative
Test Code: 16001 | CPT Code: |
Specimen Type: Sodium heparin whole blood/ bone marrow | |
Sample Volume: 3 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Sample received in any other tube. | |
Methodology: Cell culture | |
Special Requirements: Clinical details in specified format required | |
Clinical Significance: The BCR-ABL fusion gene is formed by a translocation between chromosomes 9 and 22 [t(9;22)]. The fusion gene is the hallmark diagnostic feature, being present in virtually all individuals with CML. It is also present in some adults and children with ALL. This assay aids in diagnosis of CML, identifying acute lymphoblastic leukemia (ALL) with t(9;22) BCR/ABL rearrangement (Ph+ ALL), selecting treatment inpatients with ALL, monitoring the effectiveness of therapy, monitoring minimal residual disease (MRD), and predicting disease progression. |
|
Run Day: Sat, Wed | |
Reporting Day: 21st day |
Phosphorus, 24 Hrs, Urine
Test Code: 16321 | CPT Code: 84105 |
Specimen Type: 24 hrs Urine | |
Sample Volume: 5 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: NA | |
Methodology: Spectrophotometry | |
Special Requirements: 24 hrs urine with 15 mL 6 N HCL. Refrigerate specimen within 4 hours of completion of 24-hour collection. Mention 24 hrs urine volume. | |
Clinical Significance: Approximately 80% of filtered phosphorus is reabsorbed by renal proximal tubule cells. The regulation of urinary phosphorus excretion is mainly dependent on regulation of proximal tubu-lar phosphorus reabsorption. Urinary phosphorus excretion is increased by high phosphorus diet, parathyroid hormone, extracellular volume expansion, low dietary potassium intake, proximal tubule defects (eg, Fanconi syndrome, X-linked hypophosphatemic rickets, tumor-induced osteomalacia). |
|
Run Day: Daily | |
Reporting Day: Same day |
Phosphorus, Serum
Test Code: 306 | CPT Code: 84100 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Serum phosphorus levels in isolation are of limited diagnostic value and should be correlated with serum calcium levels. An increased phosphorus with decreased calcium suggests either hypoparathyroidism or renal disease. A decreased phosphorus and an increased calcium suggests hyperparathyroidism or sarcoidosis. When both calcium and phosphorus are decreased, diagnostic considerations include malabsorption, vitamin D deficiency and renal tubular acidosis. Increased phosphorus and normal or increased calcium suggests milk-alkali syndrome or hypervitaminosis D. |
|
Run Day: Daily | |
Reporting Day: Same day |
Phosphorus, Urine
Test Code: 1090 | CPT Code: 84105 |
Specimen Type: Urine in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: NA | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: Urinary phosphorus concentration is useful to assess calcium and phosphorus balance. Thyroid and kidneys are key organs influencing urinary excretion. Many medical conditions affect urinary phosphorus levels. |
|
Run Day: Daily | |
Reporting Day: Next day |
Placenta
Test Code: 1405 | CPT Code: 88305,88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Platelet Antibody, Serum
Test Code: 8425 | CPT Code: 86022 |
Specimen Type: Serum (yellow-top tube) | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Grosshemolysis and hyperlipemic | |
Methodology: Immunofluorescence | |
Special Requirements: Do not collect within 72 hours of a platelet transfusion as the same will interfere with this assay. Clinical history is required. | |
Clinical Significance: Serum platelet antibody assay is used for detection of alloantibodies to epitopes on platelet glycoproteins IIb/IIIa, Ib/Ix, Ia/ IIa, IV and HLA Class I antigens to evaluate cases of immune mediated refractoriness to platelet transfusions, posttransfusion |
|
Run Day: Sat | |
Reporting Day: 4th day |
Platelets Count
Test Code: 459 | CPT Code: 85049 |
Specimen Type: Whole blood in a lavender-top (EDTA) tube | |
Sample Volume: 3.0 mL (1.0mL min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Grosshemolysis and clotted | |
Methodology: Cell counter | |
Special Requirements: No special precautions needed | |
Clinical Significance: Platelets must be present in adequate numbers. It plays an important role in hemostasis. |
|
Run Day: Daily | |
Reporting Day: Same day |
Polycystic Ovary Syndrome (PCOS) Profile (FSH, LH, Prolactin, Total Testosterone, Insulin Fasting, Insulin PP, FBS)
Test Code: 6239 | CPT Code: Use individual CPTCodes |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 5.0 mL | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Hemolysis/ received room temperature | |
Methodology: Immunoassay | |
Special Requirements: 10 to 12 hrs fasting is preferred for glucose and insulin fasting specimen | |
Clinical Significance: See individual assays. |
|
Run Day: Daily | |
Reporting Day: Next day |
Porphobilinogen, 24 Hrs, Quantitative, Urine
Test Code: 1254 | CPT Code: 84110 |
Specimen Type: 24 hrs Urine | |
Sample Volume: 20 mL - min | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Received room temperature. Not protected from light | |
Methodology: Chromatography/ Spectrophotometry | |
Special Requirements: 24 hours urine, without preservative. Refrigerate during collection. To protect from light, specimen should be collected in a dark coloured bottle. On TRF endorse 24 hrs total urine volume along with patient age, gender and clinical history details. | |
Clinical Significance: The porphyrias are a group of inherited disorders resulting from enzyme defects in the heme biosynthetic pathway. Depending on the specific enzyme involved, various porphyrins and their precursors accumulate in different specimen types. This assay is useful for evaluation ofa suspected acute porphyria: acute intermittent porphyria, hereditary coproporphyria, and variegate porphyria. It is |
|
Run Day: Wed | |
Reporting Day: Next day |
Porphyrins, 24 hrs, Urine, Quantitative
Test Code: 6954 | CPT Code: 84120 |
Specimen Type: 24 hrs urine in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Urine with preservative | |
Methodology: Chromatography/Spectrophotometry | |
Special Requirements: 24 hrs urine without preservative. Clinical history is mandatory. To protect from light, the urine specimen should be collected in dark colour bottle. Courier the 24 hrs urine aliquot in dark brown container. Mention 24 hrs urine volume on the requisition form. | |
Clinical Significance: Porphyria is a group of disorders characterized by the abnormal accumulation of porphyrins or porphyrin precursors. Porphyrin fractionation of urine is useful in diagnosing porphyrin cutanea tarda, hereditary coproporphyria, and variegate porphyria. |
|
Run Day: Wed | |
Reporting Day: 2nd day |
Potassium, 24 hrs, Urine
Test Code: 3998 | CPT Code: 84133 |
Specimen Type: 24 hrs urine in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: NA | |
Methodology: ISE | |
Special Requirements: 24 hrs urine without preservatives. Clinical history is mandatory. Mention 24 hrs urine volume on the requisition form. | |
Clinical Significance: Assessment of hydration status and overall electrolyte balance. |
|
Run Day: Daily | |
Reporting Day: Same day |
Potassium, Random, Urine
Test Code: 3999 | CPT Code: 84133 |
Specimen Type: Urine in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: NA | |
Methodology: ISE | |
Special Requirements: No special precautions needed | |
Clinical Significance: Assessment of hydration status and overall electrolyte balance. |
|
Run Day: Daily | |
Reporting Day: Same day |
Potassium, Serum
Test Code: 307 | CPT Code: 84132 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: ISE | |
Special Requirements: No special precautions needed | |
Clinical Significance: Potassium measurement is useful in monitoring electrolyte balance in the diagnosis and treatment of disease conditions characterized by low or high blood potassium levels. Potassium is elevated in adrenal cortical insufficiency, acute renal failure and in some cases of diabetic acidosis. Potassium is decreased in diuretic administration and renal tubular acidosis. |
|
Run Day: Daily | |
Reporting Day: Same day |
Pre Eclampsia Profile (PIGF & sFlt-1)
Test Code: 7078 | CPT Code: Use individual CPTCodes |
Specimen Type: Serum collected in yellow-top tube | |
Sample Volume: 3.0 mL | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: The PLGF and sFlt-1 concentrations are measured by immunoassay in maternal blood to improve the diagnostic possibilities in preeclampsia. |
|
Run Day: Sun | |
Reporting Day: 3rd day |
Pregnancy Test, Serum
Test Code: 1102 | CPT Code: 84703 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: ECLIA | |
Special Requirements: No special precautions needed | |
Clinical Significance: hCG may reach detectable limits within 7-10 days of conception. hCG is produced by the placenta and reaches a peak between the 7th and 10th week of gestation. hCG is a glycoprotein hormone produced by the syncytiotrophoblast of placenta and secreted during normal pregnancy and with pathologic conditions such as hydatidiform mole, choriocarcinoma and testicular neoplasm. |
|
Run Day: Daily | |
Reporting Day: Same day |
Pregnancy Test, Urine
Test Code: 1101 | CPT Code: 81025 |
Specimen Type: Urine in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: NA | |
Methodology: ECLIA | |
Special Requirements: No special precautions needed | |
Clinical Significance: This test is specific for HCG beta sub unit and offers sensitivity necessary to detect pregnancy as early as ten days post conception. |
|
Run Day: Daily | |
Reporting Day: Same day |
Prenatal Testing by Fluorescence In Situ Hybridization (FISH)
Test Code: 13192 | CPT Code: 88271 |
Specimen Type: Cord blood in Sodium heparin tube (green- top), amniotic fluid | |
Sample Volume: Blood: 3-5 mL, Amniotic fluid-10mL in sterile centrifuge tube with consent form | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Frozen | |
Methodology: FISH (Fluorescence in situ hybridization) | |
Special Requirements: Clinical history and informed consent is essential | |
Clinical Significance: Approximately half of clinically recognizable spontaneous abortions have a major chromosomal anomaly, out of which up to 95% involve aneuploidy (gain or loss of whole chromosome) of chromosomes 13, 18, 21, X, and |
|
Run Day: Daily | |
Reporting Day: 7 days |
Procalcitonin Test (PCT-Q)
Test Code: 3646 | CPT Code: 84145 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: ECLIA | |
Special Requirements: Clinical history is essential. | |
Clinical Significance: Procalcitonin (ProCT) assay is useful in diagnosis of bacteremia & septicemia in adults and children including neonates. It diagnoses renal involvement in UTI in children, bacterial infection in neutropenic patients & secondary infection post surgery. It helps in the differential diagnosis of bacterial versus viral meningitis and community acquired bacterial versus viral pneumonia. ProCT becomes detectable within 2 to |
|
Run Day: Daily | |
Reporting Day: 3rd day |
Progesterone, Serum
Test Code: 485 | CPT Code: 84144 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: ECLIA | |
Special Requirements: Clinical history and timing of specimen collection is essential | |
Clinical Significance: Levels increases sharply during the luteal phase of the menstrual cycle. The level also increases from 9 to 32 weeks of pregnancy. |
|
Run Day: Daily | |
Reporting Day: Same day |
Prolactin, Serum
Test Code: 486 | CPT Code: 84146 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis, icteric and lipemic | |
Methodology: ECLIA | |
Special Requirements: Clinical history and timing of Specimen collection is essential | |
Clinical Significance: Prolactin is a single-chain polypeptide hormone secreted by the anterior pituitary under the control of prolaction-releasing factors. These inhibiting and releasing factors |
|
Run Day: Daily | |
Reporting Day: Same day |
Prostate Specific Antigen (PSA), Free
Test Code: 1264 | CPT Code: 84154 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: ECLIA | |
Special Requirements: Direct Rectal Examination (DRE), prostatic biopsy or ejaculation prior to test should be avoided | |
Clinical Significance: In men over age 50 years with total PSA between 4.0 and 10.0 ng/mL, those with prostate cancer tend to have lower % free PSA than those with benign prostatic hypertrophy (BPH), although there is considerable overlap in results for the two populations. % free PSA may aid in avoiding unnecessary biopsies in these circumstances. |
|
Run Day: Daily | |
Reporting Day: Same day |
Prostate Specific Antigen (PSA), Total
Test Code: 1152 | CPT Code: 84153 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: ECLIA | |
Special Requirements: Direct Rectal Examination (DRE), prostatic biopsy or ejaculation prior to test should be avoided | |
Clinical Significance: Elevate serum PSA concentration have been reported in men with prostate cancer, benign prostatic hypertrophy, and inflammatory conditions of the prostate. |
|
Run Day: Daily | |
Reporting Day: Same day |
Prostate, Needle Biopsy
Test Code: 1363 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Prostate, Radical Prostatectomy for Tumor
Test Code: 1432 | CPT Code: 88309 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Prostate, Suprapubic Prostatectomy for Nodular Hyperplasia
Test Code: 1406 | CPT Code: 88307 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Prostate, Transurethral Resection (TURP)
Test Code: 1384 | CPT Code: 88305 |
Specimen Type: Tissue | |
Sample Volume: Specimen in 10% buffered formalin | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Received frozen | |
Methodology: Microscopy | |
Special Requirements: Clinical history and sample site are essential | |
Clinical Significance: The nature of possible underlying disease can be ruled out/confirmed through histopathological examination |
|
Run Day: Daily, except Fri | |
Reporting Day: 4th day |
Protective Antibodies Panel (Anti Hbs, Varicella IgG & IgM, Rubella IgG & IgM, Mumps IgG & IgM, Measles IgG & IgM Antibodies)
Test Code: 6911 | CPT Code: Use individual CPTCodes |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: serum,3.0 mL | |
Transport Condition: Refrigerated condition/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Immunoassay | |
Special Requirements: No special precautions needed | |
Clinical Significance: Protective antibody titers for a range of infectious diseases. |
|
Run Day: Sat, Tue, Thurs | |
Reporting Day: Same day |
Protein C Activity
Test Code: 6906 | CPT Code: 85303 |
Specimen Type: Citrated plasma [Whole blood in blue-top (sodium citrate) tube] | |
Sample Volume: 2.0 mL | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Clot Detection | |
Special Requirements: No special precautions needed | |
Clinical Significance: Comprehensive test assesses the total level of protein and its functional activity in determiningprotein C deficiency, which is strongly prothrombotic, and may require long term anticoagulation therapy. In the presence of low protein C Activity, protein |
|
Run Day: Wed | |
Reporting Day: Next day |
Protein Electrophoresis
Test Code: 1255 | CPT Code: 84165 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Electrophoresis | |
Special Requirements: No special precautions needed | |
Clinical Significance: Protein electrophoresis evaluates the major protein fractions to determine if there are deficiencies or excesses as seen with macroglobulinemia and multiple myeloma. Immunofixation is useful in characterizing M components. |
|
Run Day: Mon, Thurs | |
Reporting Day: Next day |
Protein Electrophoresis, CSF
Test Code: 15686 | CPT Code: 84166 |
Specimen Type: CSF | |
Sample Volume: 3.0 mL (2.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Nil | |
Methodology: Electrophoresis | |
Special Requirements: Clinical history is required | |
Clinical Significance: CSF protein electrophoresis is useful in identifying oligoclonal band, and other protein variations that are associated with multiple sclerosis and occasionally, viral illnesses. |
|
Run Day: Daily | |
Reporting Day: 3rd day |
Protein Electrophoresis, Urine
Test Code: 16394 | CPT Code: 84166 |
Specimen Type: 24 hrs urine | |
Sample Volume: 15 mL | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Nil | |
Methodology: Electrophoresis | |
Special Requirements: Refrigerate specimen during collection and send refrigerated. | |
Clinical Significance: Urine proteins can be grouped into 5 fractions by protein electrophoresis: Albumin, Alpha-1, Alpha-2, Beta-globulin and Gamma globulin. The electrophoretic pattern and the presence of a monoclonal immunoglobulin light chain may be characteristic of monoclonal gammopathies such as multiple myeloma, primary systemic amyloidosis, and light-chain deposition disease. |
|
Run Day: Mon, Thurs | |
Reporting Day: Same day |
Protein S, Free
Test Code: 6907 | CPT Code: 85306 |
Specimen Type: Citrated plasma [Whole blood in blue-top (sodium citrate) tube] | |
Sample Volume: 3.0 mL | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Hemolysis | |
Methodology: Clot Detection | |
Special Requirements: No special precautions needed | |
Clinical Significance: This test is often useful in the comprehensive evaluation of protein S when deficiency is suspected, allowing forassessment of the free protein S, separate from total protein S, which includes C4BP. The clinical use of this test is important in the evaluation of physiologically |
|
Run Day: Wed | |
Reporting Day: Next day |
Protein S, Total
Test Code: 1227 | CPT Code: 85305 |
Specimen Type: Citrated plasma [Whole blood in blue-top (sodium citrate) tube] | |
Sample Volume: 3.0 mL | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Hemolysis | |
Methodology: Clot Detection | |
Special Requirements: No special precautions needed | |
Clinical Significance: For investigation of coagulation disorders |
|
Run Day: Wed | |
Reporting Day: Next day |
Protein, 24 Hrs, Urine
Test Code: 4001 | CPT Code: 84156 |
Specimen Type: Urine in sterile leak proof container | |
Sample Volume: 10 mL | |
Transport Condition: Room temperature | |
Specimen Rejection Criteria: Acidified urine | |
Methodology: Spectrophotometry | |
Special Requirements: 24 hrs urine (with 6N HCL as preservative). Clinical history is required. Mention 24 hrs urine volume on the requisition form. | |
Clinical Significance: Proteinuria, mainly glomerular, is often a manifestation of primary renal disease although transient proteinuria may occur with fevers, thyroid disorders, and in heart diseases. In the absence of renal disease, the degree of proteinuria is slight, usually amounting to less than 2 grams per day.In chronic glomerulonephritis and in the nephrotic syndrome, including lipoid nephrosis, and in some forms of hypertensive vascular diseases, protein loss may vary from a few grams to as much as 30 g/day. |
|
Run Day: Daily | |
Reporting Day: Same day |
Prothrombin Time with INR
Test Code: 456 | CPT Code: 85610 |
Specimen Type: Citrated plasma [Whole blood in blue-top (sodium citrate) tube] | |
Sample Volume: 2.0 mL , upto the mark intube | |
Transport Condition: Refrigerated condition | |
Specimen Rejection Criteria: Hemolysis | |
Methodology: Clotting | |
Special Requirements: No special precautions needed | |
Clinical Significance: Bleeding disorder may be due to inherited or acquired deficiencies of a clotting factor |
|
Run Day: Daily | |
Reporting Day: Same day |
Pseudo Cholinesterase, Serum
Test Code: 1238 | CPT Code: 82480 |
Specimen Type: Serum collected in a yellow-top tube | |
Sample Volume: 3.0 mL (1.0mL - min) | |
Transport Condition: Refrigerated/ frozen condition | |
Specimen Rejection Criteria: Gross hemolysis | |
Methodology: Spectrophotometry | |
Special Requirements: No special precautions needed | |
Clinical Significance: The organophosphorous-containing insecticides are potent inhibitors of the true red cell cholinesterase and can cause depression of the serum pseudocholinesterase. Succinylcholine is hydrolyzed by pseudocholinesterase which, therefore influences its physiological effect. Total serum pesudocholinesterase values are decreased in patients with liver disease. |
|
Run Day: Daily | |
Reporting Day: 5th day |
PTH, Intact; including Calcium, Total
Test Code: 9998 | CPT Code: 83970,82310 |
Specimen Type: Plasma EDTA [lavender-top (EDTA) tube] for I PTH; Serum (yellow-top tube) for calcium | |
Sample Volume: 3.0 mL (1.0 mL - min) in each tube | |
Transport Condition: Frozen condition | |
Specimen Rejection Criteria: Grosshemolysis and lipemia | |
Methodology: Chemiluminescence | |
Special Requirements: 12 hours before this test do not take multivitamins or dietary supplements containing biotin or vitamin B7 | |
Clinical Significance: The major function of PTH is to maintain the serum total calcium concentration within a narrow range. The net effects of PTH are to increase the serum concentration of calcium and to decrease that of phosphate. The assay is useful in making the diagnosis of primary hyperparathyroidism, secondary hyperparathyroidism, and in differential diagnosis of hypercalcemia. The assay helps to distinguish hypercalcemia |
|
Run Day: Sun | |
Reporting Day: Same day |